GB1002649A - Novel pyrazolidone derivatives - Google Patents

Novel pyrazolidone derivatives

Info

Publication number
GB1002649A
GB1002649A GB15535/62A GB1553562A GB1002649A GB 1002649 A GB1002649 A GB 1002649A GB 15535/62 A GB15535/62 A GB 15535/62A GB 1553562 A GB1553562 A GB 1553562A GB 1002649 A GB1002649 A GB 1002649A
Authority
GB
United Kingdom
Prior art keywords
glycose
compounds
pectose
algin
dextran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB15535/62A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Frederick Co
Original Assignee
Purdue Frederick Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Frederick Co filed Critical Purdue Frederick Co
Publication of GB1002649A publication Critical patent/GB1002649A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Drying Of Solid Materials (AREA)
GB15535/62A 1961-04-24 1962-04-24 Novel pyrazolidone derivatives Expired GB1002649A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12179661A 1961-04-24 1961-04-24

Publications (1)

Publication Number Publication Date
GB1002649A true GB1002649A (en) 1965-08-25

Family

ID=22398845

Family Applications (1)

Application Number Title Priority Date Filing Date
GB15535/62A Expired GB1002649A (en) 1961-04-24 1962-04-24 Novel pyrazolidone derivatives

Country Status (6)

Country Link
BR (1) BR6238369D0 (pt)
DE (1) DE1470148A1 (pt)
DK (1) DK101791C (pt)
FI (2) FI43993B (pt)
GB (1) GB1002649A (pt)
NO (1) NO117481B (pt)

Also Published As

Publication number Publication date
FI48735B (pt) 1974-09-02
FI48735C (fi) 1974-12-10
FI43993B (pt) 1971-04-30
DK101791C (da) 1965-05-31
NO117481B (pt) 1969-08-18
DE1470148A1 (de) 1969-06-04
BR6238369D0 (pt) 1973-05-10

Similar Documents

Publication Publication Date Title
ES382751A1 (es) Procedimiento para la preparacion de composiciones herbici-das.
ES421430A1 (es) Procedimiento para producir derivados carbostirilo.
GB1002649A (en) Novel pyrazolidone derivatives
ES392093A1 (es) Procedimiento para la preparacion de derivados del amino-2 cloro-5-tiazol.
GB1084700A (en) Thiosemicarbazones and their production
ES389473A1 (es) Un procedimiento de preparacion de derivados de aminocarbo-nil-3 oxazolidinona-2.
GB1393451A (en) Pharmaceutical compositions containing a 1-phenoxy-3-alkoxy- 2-propanol
GB1390487A (en) Pharmaceutical compositions containing diphenylmethane deri vatives
ES419439A1 (es) Procedimiento para la preparacion de nuevos derivados de carbamoil-sulfoxido.
ES419386A1 (es) Un procedimiento para la preparacion de nuevos derivados deindenopirrol.
GB1351775A (en) 5-methyldipyrazolo-3,4-6,3,4,-d-pyridin-3-2h-ones
GB1158473A (en) Derivatives of Benzothiopyrone and process for preparing them
GB955353A (en) Improvements in or relating to novel pyridine derivatives
GB849755A (en) Pharmaceutical preparations comprising ª‡-dialkylamino-propiophenones
GB1000783A (en) Improvements in or relating to pharmaceutical compositions containing polyhydroxybenzene derivatives
ES390754A1 (es) Procedimiento para la preparacion de nuevos derivados de tiazoloquinolina.
GB1071471A (en) Amides of 2,6-dichloro-aniline and a nitrogen substituted amino-acid
ES351413A1 (es) Procedimiento para la preparacion de 1-(piridil)-1,2,3,4- tetrahidroisoquinoleinas.
ES370226A1 (es) Procedimiento para la preparacion de compuestos derivados de cicloheptimidazolona.
ES381209A1 (es) Un procedimiento para preparar nuevas 1,2-difenil-3,5-dio- xo-pirazolidinas sustituidas en la posicion 4.
ES441029A1 (es) Procedimiento de preparacion de un nuevo derivado del acido acetilsalicilico.
ES441002A1 (es) Un procedimiento para preparar oxaprostaglandinas.
GB1067203A (en) Improvements in or relating to the production of isoxazole compounds and the products thereof
GB933509A (en) Enol acylates of furan derivatives
ES243594A1 (es) Procedimiento de obtenciën de derivados de ferroceno